STAGE IIA BREAST CANCER
Clinical trials for STAGE IIA BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIA BREAST CANCER trials appear
Sign up with your email to follow new studies for STAGE IIA BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo offers hope for elderly breast cancer patients avoiding surgery
Disease control CompletedThis study tested a combination of two hormone-based drugs (fulvestrant and palbociclib) in 14 older patients with hormone-sensitive breast cancer who could not have surgery or chose not to. The goal was to control the cancer and avoid the need for surgery. The treatment aims to …
Matched conditions: STAGE IIA BREAST CANCER
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 11:42 UTC
-
9-Day radiation blitz shows promise for early breast cancer
Disease control CompletedThis study tested a shorter, higher-dose radiation schedule for people with early-stage breast cancer (stages 0 to IIB). Instead of the usual several weeks, treatment was completed in just 9 days. The goal was to see if this approach could control the cancer while causing fewer s…
Matched conditions: STAGE IIA BREAST CANCER
Phase: PHASE2 • Sponsor: University of Utah • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New combo therapy may keep breast cancer from coming back
Disease control CompletedThis study tested whether adding ovarian suppression (stopping the ovaries from making estrogen) and switching to a different hormone drug (exemestane) could better prevent breast cancer from returning in premenopausal women with hormone-sensitive breast cancer. Over 3,000 women …
Matched conditions: STAGE IIA BREAST CANCER
Phase: PHASE3 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated May 22, 2026 13:51 UTC